Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Journal of Clinical Nursing
|
October 26, 2016
'Clinical Chatter': every nurse informed
Carolyn Talbott, Lynn Watson, Joseph Tariman, et al.
Cancer Nursing
|
May 6, 2008
Expanding role of bortezomib in multiple myeloma: nursing implications
Kathleen Colson, Deborah S Doss, Regina Swift, et al.
Applied Nursing Research : ANR
|
June 23, 2015
Factors related to sexual behaviors and sexual education programs for Asian-American adolescents
Young-Me Lee, Elizabeth Florez, Joseph Tariman, et al.
Clinical Journal of Oncology Nursing
|
November 2, 2004
Bortezomib, a newly approved proteasome inhibitor for the treatment of multiple myeloma: nursing implications
Kathleen Colson, Deborah S Doss, Regina Swift, et al.
Oncology Nursing Forum
|
March 11, 2009
Self-care strategies to cope with taste changes after chemotherapy
Maureen Rehwaldt, Rita Wickham, Sandy Purl, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
|
July 24, 2023
Using the Caprini Risk Score to Increase Awareness of Venous Thrombus Embolism in the Community: Know Your Score II
Chunping Huang, Joseph Tariman, Shannon Simonovich, et al.
Blood
|
December 2, 2006
Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study
Asher A Chanan-Khan, Jonathan L Kaufman, Jayesh Mehta, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 15, 2013
Myeloma is characterized by stage-specific alterations in DNA methylation that occur early during myelomagenesis
Christoph J Heuck, Jayesh Mehta, Tushar Bhagat, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Journal of Clinical Nursing
|
October 26, 2016
'Clinical Chatter': every nurse informed
Carolyn Talbott, Lynn Watson, Joseph Tariman, et al.
Cancer Nursing
|
May 6, 2008
Expanding role of bortezomib in multiple myeloma: nursing implications
Kathleen Colson, Deborah S Doss, Regina Swift, et al.
Applied Nursing Research : ANR
|
June 23, 2015
Factors related to sexual behaviors and sexual education programs for Asian-American adolescents
Young-Me Lee, Elizabeth Florez, Joseph Tariman, et al.
Clinical Journal of Oncology Nursing
|
November 2, 2004
Bortezomib, a newly approved proteasome inhibitor for the treatment of multiple myeloma: nursing implications
Kathleen Colson, Deborah S Doss, Regina Swift, et al.
Oncology Nursing Forum
|
March 11, 2009
Self-care strategies to cope with taste changes after chemotherapy
Maureen Rehwaldt, Rita Wickham, Sandy Purl, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
|
July 24, 2023
Using the Caprini Risk Score to Increase Awareness of Venous Thrombus Embolism in the Community: Know Your Score II
Chunping Huang, Joseph Tariman, Shannon Simonovich, et al.
Blood
|
December 2, 2006
Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study
Asher A Chanan-Khan, Jonathan L Kaufman, Jayesh Mehta, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 15, 2013
Myeloma is characterized by stage-specific alterations in DNA methylation that occur early during myelomagenesis
Christoph J Heuck, Jayesh Mehta, Tushar Bhagat, et al.
Page
of 1